| VAS score |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
-34.7±18.4 |
-30 |
-80 to -10 |
-14.4±21.5 |
-15 |
-70 to 25 |
0.001† |
| Pre-treatment vs. 12th weeks |
-37.8±17.6 |
-30 |
-80 to -10 |
-14.3±19.2 |
-12.5 |
-70 to 20 |
0.001† |
| HAQ score |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
-3.9±6.3 |
-3 |
-19 to 12 |
-1.1±6.8 |
-0.5 |
-18 to 22 |
0.048† |
| Pre-treatment vs. 12th weeks |
-5.3±6.0 |
-4 |
-23 to 4 |
0.2±6.7 |
-0.5 |
-12 to 23 |
0.001† |
| ODI score |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
-9.8±8.7 |
-10.5 |
-34 to 12 |
-3.2±6.8 |
-3.5 |
-20 to 16 |
0.001† |
| Pre-treatment vs. 12th weeks |
-11.1±7.2 |
-9.5 |
-28 to 3 |
-2.7±7.2 |
-3.5 |
-20 to 14 |
0.001† |
| FTFD |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
-2.9±4.6 |
-1 |
-17 to 5 |
-1.4±8.3 |
0 |
-38.7 to 20 |
0.020† |
| Pre-treatment vs. 12th weeks |
-3.7±4.8 |
-2 |
-18.5 to 1 |
-1.3±10.4 |
0 |
-38.7 to 39.9 |
0.009† |
| TPPT |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
160.9±66.8 |
155.15 |
35.3 to 291.7 |
9.2±100.2 |
-3.25 |
-245.3 to 285.1 |
0.001† |
| Pre-treatment vs. 12th weeks |
127.7±78.8 |
124.1 |
-9.2 to 339 |
-27.8±102.0 |
-10.35 |
-325.8 to 182.4 |
0.001† |
| BDI score |
|
|
|
|
|
|
|
| Pre-treatment vs. 1st week |
-3.8±7.7 |
-3 |
-22 to 18 |
-5.7±9.9 |
-3 |
-43 to 9 |
0.953† |
| Pre-treatment vs. 12th weeks |
-5.4±6.5 |
-4.5 |
-22 to 12 |
-3.9±6.7 |
-3 |
-20 to 12 |
0.349† |
| VAS: Visual Analog Scale; HAQ: Health Assessment Questionnaire; ODI: Oswestry Disability Index; FTFD: Fingertip-to-floor distance; PPT: Pressure pain threshold; BDI: Beck Depression Inventory; ESWT: Extracorporeal shock wave therapy; CPT: Conventional physical therapy; SD: Standard deviation; TPPT: Total pressure pain threshold; † Statistical comparison of change in measurements between groups with the Mann-Whitney U test; Negative values represent decrease in scores and positive values represent increase in scores. |
